Satellos Bioscience Inc. (MSCLF)
USD 0.48
(-4.42%)
USD 0.48
(-4.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 6.64 Million CAD | -20.68% |
| 2022 | 8.37 Million CAD | 84.54% |
| 2021 | 4.54 Million CAD | 218.16% |
| 2020 | 1.42 Million CAD | -35.21% |
| 2019 | 2.2 Million CAD | 0.11% |
| 2018 | 2.2 Million CAD | 51.75% |
| 2017 | 1.44 Million CAD | 20.45% |
| 2016 | 1.2 Million CAD | -45.03% |
| 2015 | 2.18 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.25 Million CAD | 32.12% |
| 2024 Q2 | 6.67 Million CAD | -78.12% |
| 2023 Q2 | 3.03 Million CAD | 84.57% |
| 2023 FY | 8.22 Million CAD | -1.8% |
| 2023 Q3 | 4.48 Million CAD | 47.72% |
| 2023 Q1 | 1.64 Million CAD | -28.02% |
| 2023 Q4 | 6.24 Million CAD | 39.22% |
| 2022 Q1 | 2.12 Million CAD | 48.77% |
| 2022 FY | 8.37 Million CAD | 84.54% |
| 2022 Q4 | 2.28 Million CAD | 30.21% |
| 2022 Q3 | 1.75 Million CAD | -19.12% |
| 2022 Q2 | 2.17 Million CAD | 1.97% |
| 2021 Q3 | 1.44 Million CAD | 183.71% |
| 2021 Q1 | 843.57 Thousand CAD | 428.08% |
| 2021 Q2 | 507.71 Thousand CAD | -39.81% |
| 2021 FY | 4.54 Million CAD | 218.16% |
| 2021 Q4 | 1.43 Million CAD | -0.63% |
| 2020 Q4 | 159.74 Thousand CAD | 2.71% |
| 2020 Q3 | 155.52 Thousand CAD | -51.86% |
| 2020 Q2 | 323.04 Thousand CAD | 34.31% |
| 2020 Q1 | 240.51 Thousand CAD | 0.0% |
| 2020 FY | 1.42 Million CAD | -35.21% |
| 2019 FY | 2.2 Million CAD | 0.11% |
| 2018 FY | 2.2 Million CAD | 51.75% |
| 2017 FY | 1.44 Million CAD | 20.45% |
| 2016 FY | 1.2 Million CAD | -45.03% |
| 2015 FY | 2.18 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 29.55 Million USD | 77.512% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -31.812% |
| CSL Limited | 3.44 Billion USD | 99.807% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 82.161% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -619.646% |
| BioStem Technologies, Inc. | 22.97 Million USD | 71.073% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 38.842% |
| Qrons Inc. | 643.67 Thousand USD | -932.505% |
| Nascent Biotech, Inc. | 2.22 Million USD | -198.043% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 88.43% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 1.072% |
| Skye Bioscience, Inc. | 13.54 Million USD | 50.943% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -1499.599% |
| Rebus Holdings, Inc. | 664 Thousand USD | -900.904% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 58.489% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -397.667% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.195% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -1606.001% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 92.342% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -35.139% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -2439.297% |
| SQZ Biotechnologies Company | 85.61 Million USD | 92.238% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -127.897% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -342.506% |
| Mesoblast Limited | 5.9 Million USD | -12.606% |
| Marizyme, Inc. | 19.23 Million USD | 65.457% |
| Genus plc | 147.7 Million USD | 95.5% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 24.299% |
| Pharming Group N.V. | 225.49 Million USD | 97.053% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -224.4% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -395.399% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 20.302% |
| ContraFect Corporation | 56.88 Million USD | 88.318% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -50.748% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -349.433% |
| IMV Inc. | 37.7 Million USD | 82.376% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -138.177% |
| MultiCell Technologies, Inc. | 567.42 USD | -1171166.434% |
| ONE Bio Corp. | 6.44 Million USD | -3.136% |
| Accustem Sciences Inc. | 3.74 Million USD | -77.396% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 92.267% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -1149.337% |
| Q BioMed Inc. | 3.43 Million USD | -93.387% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 73.109% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -152.938% |
| Biomind Labs Inc. | 994.18 Thousand USD | -568.489% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 93.309% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -277.683% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -256.474% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 26684.0% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -262.161% |
| GB Sciences, Inc. | 1.42 Million USD | -367.86% |
| Alpha Cognition Inc. | 9.7 Million USD | 31.524% |
| HST Global, Inc. | 140.9 Thousand USD | -4616.586% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -490.803% |
| Halberd Corporation | 74.84 Thousand USD | -8780.041% |
| Enzolytics Inc. | 2.17 Million USD | -204.931% |
| Agentix Corp. | 1.37 Million USD | -384.488% |
| Resverlogix Corp. | 12.71 Million USD | 47.719% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -82.047% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.567% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -536.59% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -176.349% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -320.805% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -95.185% |
| AVAX Technologies, Inc. | 7.31 Million USD | 9.087% |
| Zenith Capital Corp. | 8.94 Million USD | 25.685% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -38049.36% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -170.678% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -3775.015% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -245.983% |
| Kadimastem Ltd | 2.41 Million USD | -175.755% |
| Helix BioMedix, Inc. | 1.97 Million USD | -237.012% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -3562.011% |
| LadRx Corporation | 3.81 Million USD | -74.354% |
| Cell Source, Inc. | 4.32 Million USD | -53.652% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -619.646% |
| NovAccess Global Inc. | 2.46 Million USD | -169.422% |
| Affymax, Inc. | 39.38 Million USD | 83.126% |
| Itoco Inc. | 919.14 Thousand USD | -623.065% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -56.804% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -493.923% |
| Mobile Lads Corp. | 554.54 Thousand USD | -1098.458% |
| CytoDyn Inc. | 18.05 Million USD | 63.196% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -26305.499% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -2919.838% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -368.097% |
| SYBLEU INC | 160.87 Thousand USD | -4031.132% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -265.905% |
| International Stem Cell Corporation | 5.27 Million USD | -26.086% |
| Bioxytran, Inc. | 3.82 Million USD | -73.972% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -12524.9% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -32569.714% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 81.674% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -310.754% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -803.192% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -113.629% |
| Neutra Corp. | 243.82 Thousand USD | -2625.77% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 61.929% |
| PureTech Health plc | 144.59 Million USD | 95.404% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 67.564% |
| IXICO plc | 4.7 Million USD | -41.194% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 24.452% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 94.356% |
| CSL Limited | 3.89 Billion USD | 99.829% |
| Cellectis S.A. | 97.32 Million USD | 93.171% |